Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Anticuerpos Primarios

Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9) (VK661013)

Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9)
Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9)
Precio(USD):
Especificación:
  • 50ug
  • 100ug
  • 1mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoVK661013
Reactividad de especiesZaire ebolavirus (ZEBOV) (Zaire Ebola virus)
AplicacionesELISA, WB
Especie huéspedHuman
ClonalidadMonoclonal
IsotipoIgG
ID de clonF9
Objetivo VP35, Polymerase cofactor VP35, Ebola VP35, eVP35
Nivel de endotoxinas Please contact with the lab for this information.
Pureza >95% as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso Q05127
RRID Anti-ZEBOV VP35/Polymerase cofactor VP35 Antibody (F9) (abinScience Cat# VK661013, RRID:AB_3727248)
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Información de uso del producto
Aplicación Dilución
ELISA 1:2000-1:20000
WB 1:500-1:2000
Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Fondo

Polymerase cofactor VP35 is a ~37 kDa protein. Plays an essential role in viral RNA synthesis and also a role in suppressing innate immune signaling. Acts as a polymerase cofactor in the RNA polymerase transcription and replication complexes. Serves as nucleoprotein/NP monomer chaperone prior to the formation of the large oligomeric RNA-bound complexes. Part of the external layer of the nucleocapsid, likely tethering the nucleocapsid to the matrix and membrane. Regulates RNA synthesis by modulating NP-RNA interactions and interacting with DYNLL1.

1. Basler, CF. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America 97, 12289-94. PMID: 11027311
2. van Tol, S. et al. (2022) PLoS pathogens 18, e1010532. PMID: 35533195
3. Enterlein, S. et al. (2006) Antimicrobial agents and chemotherapy 50, 984-93. PMID: 16495261
4. Brown, CS. et al. (2014) Journal of molecular biology 426, 2045-58. PMID: 24495995
5. Mühlberger, E. et al. (1999) Journal of virology 73, 2333-42. PMID: 9971816
6. Watanabe, R. et al. (2024) Cell 187, 5587-5603.e19. PMID: 39293445
7. Luthra, P. et al. (2015) Journal of virology 89, 5148-53. PMID: 25741013
8. Leung, DW. et al. (2015) Cell reports 11, 376-89. PMID: 25865894
9. Yen, BC. et al. (2016) Journal of virology 90, 5108-5118. PMID: 26962215
10. Luthra, P. et al. (2013) Cell host & microbe 14, 74-84. PMID: 23870315
Nota For research use only.
Imágenes
  • Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9)

    SDS-PAGE

    SDS-PAGE for Anti-ZEBOV VP35/Polymerase cofactor VP35 Antibody (F9)

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores